These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3911928)

  • 41. Comparison of the occurrence of antibodies to human cytomegalovirus as demonstrated by complement fixation, enzyme-linked-immunosorbent assay and indirect immunofluorescence.
    Landini MP; Re MC; Coppolecchia P
    Boll Ist Sieroter Milan; 1982; 61(4):320-3. PubMed ID: 6100235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
    Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE
    Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose praziquantel for neurocysticercosis: efficacy and tolerability.
    Bittencourt PR; Gracia CM; Gorz AM; Mazer S; Oliveira TV
    Eur Neurol; 1990; 30(4):229-34. PubMed ID: 2209679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Periodic lateralized epileptiform discharges in neurocysticercosis].
    De Carvalho-Filho P; Arruda OM; De Melo-Souza SE
    Arq Neuropsiquiatr; 1989 Mar; 47(1):94-9. PubMed ID: 2764755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An investigation of the Mycoplasma pneumoniae infections in Cambridge in 1983 using mu-capture enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IF) and complement fixation (CF) tests.
    Wreghitt TG; Sillis M
    Isr J Med Sci; 1987 Jun; 23(6):704-8. PubMed ID: 3117733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic information from serological tests in human toxoplasmosis. I. A comparative study of hemagglutination, complement fixation, IgG and IgM-immunofluorescence tests in 3,752 serum samples.
    Camargo ME; Leser PG; Leser WS
    Rev Inst Med Trop Sao Paulo; 1976; 18(4):215-26. PubMed ID: 788113
    [No Abstract]   [Full Text] [Related]  

  • 47. ELISA in the evaluation of therapeutic response to albendazole in neurocysticercosis.
    Husain N; Shukla N; Kumar R; Husain M; Chaturvedi A; Agarwal GG; Gupta RK
    J Infect; 2008 Jan; 56(1):65-73. PubMed ID: 17988742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cysticercal meningitis--a pernicious form of neurocysticercosis which responds poorly to praziquantel.
    Joubert J
    S Afr Med J; 1990 May; 77(10):528-30. PubMed ID: 2343353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of an IgG-ELISA strategy using Taenia solium metacestode somatic and excretory-secretory antigens for diagnosis of neurocysticercosis revealing biological stage of the larvae.
    Sahu PS; Parija SC; Narayan SK; Kumar D
    Acta Trop; 2009 Apr; 110(1):38-45. PubMed ID: 19183550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum and cerebrospinal fluid examinations in the diagnosis of Borrelia infection in Bell's palsy.
    Jonsson L; Stiernstedt G; Carlson J; Strömberg A; Sjöberg O; Larsson A
    Acta Otolaryngol; 1990; 110(5-6):421-6. PubMed ID: 2284917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study on the culture medium antigens of Cystcercus cellulosae for detecting antibodies of cysticercosis by means of ABC-ELISA.
    Guo H; Zhao ZF; Shi DZ
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():125-7. PubMed ID: 9656362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human fascioliasis in Cajamarca/Peru. II. Humoral antibody response and antigenaemia.
    Knobloch J
    Trop Med Parasitol; 1985 Jun; 36(2):91-3. PubMed ID: 4023558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of enzyme-linked immunosorbent assay in serological diagnosis of human neurocysticercosis using paired samples of serum and cerebrospinal fluid.
    Cho SY; Kim SI; Kang SY; Choi DY; Suk JS; Choi KS; Ha YS; Chung CS; Myung HJ
    Kisaengchunghak Chapchi; 1986 Jun; 24(1):25-41. PubMed ID: 12886105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical, radiological and cerebrospinal fluid presentation of neurocysticercosis: a prospective study.
    Bittencourt PR; Costa AJ; Oliveira TV; Gracia CM; Gorz AM; Mazer S
    Arq Neuropsiquiatr; 1990 Sep; 48(3):286-95. PubMed ID: 2264783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of two Taenia solium cysticercal antigenic preparations (vesicular fluid and a glycoprotein fraction with affinity for lentil lectin) for the immunodiagnosis of neurocysticercosis by enzyme-linked immunosorbent assay (ELISA).
    Suzuki LA; Rossi CL
    Arq Neuropsiquiatr; 2011 Jun; 69(3):470-4. PubMed ID: 21755124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
    Overbosch D
    Schweiz Med Wochenschr; 1992 Jun; 122(23):893-8. PubMed ID: 1615299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [CT follow-up of neurocysticercosis treated with praziquantel].
    Schwartz A; Aulich A; Hammer B
    Radiologe; 1987 May; 27(5):237-42. PubMed ID: 3615856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Praziquantel in the treatment of cysticercosis.
    Levin JA; Smith JG
    JAMA; 1986 Jul; 256(3):349-50. PubMed ID: 3723720
    [No Abstract]   [Full Text] [Related]  

  • 59. Discrimination of elevated immunoglobulin concentrations in CSF due to inflammatory reaction of the central nervous system and blood-brain-barrier dysfunction.
    Eickhoff K; Heipertz R
    Acta Neurol Scand; 1977 Dec; 56(6):475-82. PubMed ID: 605772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bayesian Validation of the Indirect Immunofluorescence Assay and Its Superiority to the Enzyme-Linked Immunosorbent Assay and the Complement Fixation Test for Detecting Antibodies against Coxiella burnetii in Goat Serum.
    Muleme M; Stenos J; Vincent G; Campbell A; Graves S; Warner S; Devlin JM; Nguyen C; Stevenson MA; Wilks CR; Firestone SM
    Clin Vaccine Immunol; 2016 Jun; 23(6):507-514. PubMed ID: 27122484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.